Nutrition Research
Volume 25, Issue 3 , Pages 295-304 , March 2005

Oral immunoadjuvant activity of a new synbiotic Lactobacillus casei subsp casei in conjunction with dextran in BALB/c mice

Received 20 October 2003 ,Revised 27 September 2004 ,Accepted 9 October 2004.

References 

  1. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989;66(5):365–378
  2. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek. 2002;82(1-4):279–289
  3. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, Molin G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 1998;85(1):88–94
  4. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis. 2001;22(4):599–605
  5. Perdigón G, de Macias ME, Alvarez S, Oliver G, de Ruiz Holgado AA. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 1986;53(2):404–410
  6. Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol. Cell Biol. 2000;78(1):67–73
  7. Rolfe RD. The role of probiotics cultures in the control of gastrointestinal health. J. Nutr. 2000;130(2S Suppl.):396S–402S
  8. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995;125(6):1401–1412
  9. Gibson GR, Wang X. Bifidogenic properties of different types of fructo-oligosaccharides. Food Microbiol. 1994;11(6):491–498
  10. Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J. Appl. Bacteriol. 1993;74(6):667–674
  11. MacGillivray PC, Finlay HVL, Binns TB. Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants. Scott. Med. J. 1959;4:182–189
  12. Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fructooligosaccharides on intestinal flora and human health. Bifidobact. Microflora. 1986;5(1):37–50
  13. Mitsuoka T. A color atlas of anaerobic bacteria. Tokyo: Soubunsha, Co, Ltd; 1980;
  14. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol. Immunol. 1996;11(4):266–273
  15. Madden TL, Tatusov RL, Zhang J. Applications of network BLAST server. Methods Enzymol. 1996;266:131–141
  16. Ogawa T, Shimauchi H, Hamada S. Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally. Infect. Immun. 1989;57(11):3466–3471
  17. Sidebotham RL. Dextrans. Adv. Carbohydr. Chem. Biochem. 1974;30:371–444
  18. Olano-Martin E, Mountzouris KC, Gibson GR, Rastall RA. In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria. Br. J. Nutr. 2000;83(3):247–255
  19. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 1999;69(5):1052S–1057S
  20. Matsuzaki T, Yokokura T, Mutai M. Antitumor effect of intrapleural administration of Lactobacillus casei in mice. Cancer Immunol. Immunother. 1988;26(3):209–214
  21. Kato I, Kobayashi S, Yokokura T, Mutai M. Antitumor activity of Lactobacillus casei in mice. Gann. 1981;72(4):517–523
  22. Sato K, Saito H, Tomioka H. Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei. Microbiol. Immunol. 1988;32(7):689–698
  23. Miake S, Nomoto K, Yokokura T, Yoshikai Y, Mutai M, Nomoto K. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice. Infect. Immun. 1985;48(2):480–485
  24. Ogawa M, Shimizu K, Nomoto K, Takahashi M, Watanuki M, Tanaka R, et al. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect. Immun. 2001;69(2):1101–1108
  25. Apella MC, Gonzalez SN, Nader de Macias ME, Romero N, Oliver G. In vitro studies on the growth of Shigella sonnei by Lactobacillus casei and Lact. acidophilus. J. Appl. Bacteriol. 1992;73(6):480–483
  26. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child. 1995;72(1):51–53
  27. Shida K, Makino K, Morishita A, Takamizawa K, Hachimura S, Ametani A, et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allergy Immunol. 1998;115(4):278–287
  28. Ogawa T, Kotani S, Shimauchi H. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Methods Find. Exp. Clin. Pharmacol. 1986;8(2):117–125
  29. Ogawa T, Shimauchi H, Kusumoto Y, Hamada S. Humoral immune response to Bacteroides gingivalis fimbrial antigen in mice. Immunology. 1990;69(1):8–13
  30. Shimauchi H, Ogawa T, Hamada S. Immune response gene regulation of the humoral immune response to Porphyromonas gingivalis fimbriae in mice. Immunology. 1991;74(2):362–364
  31. Ogawa T, Kusumoto Y, Kiyono H, McGhee JR, Hamada S. Occurrence of antigen-specific B cells following oral or parenteral immunization with Porphyromonas gingivalis fimbriae. Int. Immunol. 1992;4(9):1003–1010
  32. Ogawa T, Shimauchi H, Furuta R, Kawata S, Yokogawa K, Kotani S. Oral immunoadjuvant activity of lipophilic derivatives of N-acetylglucosaminyl-β(1→4)-N-acetylmuramyl-l-alanyl-d-isoglutaminyl-(l)-2,6-meso-diaminopimeric acid-(d)-amide. Vaccine. 1995;13(10):887–889

PII: S0271-5317(05)00011-4

doi: 10.1016/j.nutres.2004.10.012

Nutrition Research
Volume 25, Issue 3 , Pages 295-304 , March 2005

Article Tools

* Image Usage & Resolution